Hypothyroidism among pediatric cancer patients: A nationwide, registry-based study

International Journal of Cancer

Volumn 122, Issue 8, 2008, Pages 1868-1872

  Madanat, Laura Maria S ^a,b   Lähteenmäki, Päivi M ^a   Hurme, Saija ^c   Dyba, Tadeusz ^b   Salmi, Toivo T ^a   Sankila, Risto ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c Turku University   (Finland)

Author keywords

Cancer; Child; Hypothyroidism; Late effect; Thyroxin

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; SEX RATIO; THYROID CANCER; ECONOMICS; HEALTH INSURANCE; INCIDENCE; INFANT; MEDICAL RECORD; NEOPLASM; NEWBORN; PRESCHOOL CHILD; PREVALENCE; PROPORTIONAL HAZARDS MODEL; REGISTER; STATISTICS; SURVIVOR; THYROID FUNCTION TEST;

THYROXINE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; INCIDENCE; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH; MALE; MEDICAL RECORD LINKAGE; NEOPLASMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEX DISTRIBUTION; SURVIVORS; THYROID FUNCTION TESTS; THYROXINE;

EID: 40349091425     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23277     Document Type: Article

References (21)

1. Moller TR, Garwicz S, Barlow L, Falck Winther J, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, Tulinius H. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001;19:3173-81.
2. Oeffinger KC, Eshelman DA, Tomlinson GE, Buchanan GR, Foster BM. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 2000;88:1687-95.
3. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S, Robison L. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227-32.
4. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
5. Spoudeas HA. Growth and endocrine function after chemotherapy and radiotherapy in childhood. Eur J Cancer 2002;38:1748-59; discussion 60-1.
6. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr 1986;108:219-23.
7. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE, Heideman RL. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999;84:4472-9.
8. Metzger ML, Hudson MM, Somes GW, Shorr RI, Li CS, Krasin MJ, Shelso J, Pui CH, Howard SC. White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma. J Clin Oncol 2006;24:1516-21.
9. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
10. Helin-Salmivaara A, Klaukka T, Huupponen R. Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland. Eur J Clin Pharmacol 2003;59:477-82.
11. Breslow NE, Day NE. Statistical methods in cancer research, Vol. 2: The design and analysis of cohort studies. Lyon, France: IARC, 1987;1-406.
12. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Muller J. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 2003;88:3149-54.
13. Heikens J, Michiels EM, Behrendt H, Enden E, Bakker PJ, Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer 1998;34:1592-7.
14. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004;5:399-408.
15. Berger C, Le-Gallo B, Donadieu J, Richard O, Devergie A, Galambrun C, Bordigoni P, Vilmer E, Plouvier E, Perel Y, Michel G, Stephan JL. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 2005;35:991-5.
16. Flandin I, Hartmann O, Michon J, Pinkerton R, Coze C, Stephan JL, Fourquet B, Valteau-Couanet D, Bergeron C, Philip T, Carrie C. Impact of TBI on late effects in children treated by megatherapy for stage IV neuroblastoma. A study of the French society of pediatric oncology. Int J Radiat Oncol Biol Phys 2006;64:1424-31.
17. Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 2005;63:1568-75.
18. Livesey EA, Brook CG. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 1989;64:593-5.
19. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr 1991;119:733-7.
20. Rose SR, Schreiber RE, Kearney NS, Lustig RH, Danish RK, Burghen GA, Hudson MM. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 2004;17:55-66.
21. Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, Tan C, Sklar C. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003;97:2397-403.